Amgen (AMGN) Tops Q4 EPS by 24c

Go back to Amgen (AMGN) Tops Q4 EPS by 24c

Amgen (AMGN) Reports Q4 Beat

February 7, 2022 4:59 PM EST

Amgen (NASDAQ: AMGN) reported its Q4 results, with EPS coming in at $4.36, beating the consensus estimate of $4.12. Revenue grew 3% year-over-year to $6.85 billion, slightly missing the consensus estimate of $6.88 billion, driven by increased Other Revenue from the Eli Lilly and Company COVID-19 manufacturing collaboration.

Total... More